Cellebrite DI Ltd. (NASDAQ:CLBT) Shows Strong Q1 Growth Despite Analyst Price Target Adjustment

Font: Financial Modeling Prep  • May 15, 2026

• Needham lowered its price target for Cellebrite DI Ltd. to $15.00, yet the new target still suggests a 15.12% potential upside from the stock's trading price of $13.03 at the time.
• Cellebrite DI Ltd. reported robust first-quarter 2026 results, with quarterly earnings of $0.12 per share beating estimates and revenues growing 19% year-over-year to $128.3 million.
• The company demonstrated strong recurring revenue growth, with Annual Recurring Revenue (ARR) increasing 21% to $493 million and adjusted EBITDA rising 29% to $30.6 million.

Cellebrite DI Ltd. (NASDAQ:CLBT) is a leading digital intelligence company. It provides essential tools for law enforcement and enterprises to conduct thorough digital investigations. With a market capitalization of approximately $3.23 billion, Cellebrite DI Ltd. focuses on innovative mobile device access, cloud data analysis, and comprehensive case management solutions within the rapidly evolving digital forensics market.

On May 15, 2026, analyst firm Needham lowered its price target for Cellebrite DI Ltd. to $15.00 from a previous target of $18.00. When the new target was published, the stock was trading at $13.03. This new price target still indicates a potential upside of approximately 15.12% from its price at the time, suggesting continued confidence in Cellebrite DI Ltd.'s stock performance.

This price target adjustment comes despite Cellebrite DI Ltd. reporting strong first-quarter 2026 results. As highlighted by Zacks, Cellebrite DI Ltd. announced quarterly earnings of $0.12 per share, beating estimates of $0.11 per share. The company also posted revenues of $128.3 million, which is a 19% increase from the same period a year ago, showcasing impressive revenue growth.

A key metric, Annual Recurring Revenue (ARR), grew 21% year-over-year to $493 million. ARR is the value of the contracted recurring revenue components of term-based subscription agreements. This growth was driven by a 23% increase in subscription revenue. The company’s adjusted EBITDA, a crucial measure of profitability, also grew 29% to $30.6 million.

As highlighted by PR Newswire, management notes an enthusiastic customer response to new offerings in AI, cloud management, and drone forensics. Cellebrite DI Ltd. states it is excited about its prospects to accelerate ARR expansion in the upcoming quarter, signaling confidence in its future performance and innovation pipeline.